Hamade's Compass Leads to Aberdare
This article was originally published in Start Up
Executive Summary
In the eyes of one West Coast device VC, Sami Hamade has the perfect resume to be a venture capitalist. He spent over a decade at Guidant creating or funding new start-up ventures, both internally and externally. He's sat on boards, demonstrated market savvy and established connections with all the right venture firms and laboratories in Silicon Valley. Now Hamade is prepared to do the job at Aberdare Ventures, a small but highly regarded venture firm based in San Francisco.
You may also be interested in...
Neurostimulation Market Expanding
According to Medtech Insight’s recently published report, US Markets for Neurostimulation Products, the frontier for neural stimulation is expanding rapidly, representing a $628 million market in 2006 that is forecast to grow by over 20% each year to produce sales approaching $2 billion in 2012. Topics discussed include implantable pulse generators, device reimbursement, and current and emerging applications for neurostimulation.
How To Fix A Guidant: Boston Scientific's Tobin Opens Playbook
Boston Scientific CEO Jim Tobin, in a series of addresses, defends his company's decision to spend $27.3 billion on Guidant Inc., warts and all. Defying criticism of the deal, Tobin lays out how Boston Scientific management corrected Guidant's problems--and why the new company will thrive.
How To Fix A Guidant: Boston Scientific's Tobin Opens Playbook
Boston Scientific CEO Jim Tobin, in a series of addresses, defends his company's decision to spend $27.3 billion on Guidant Inc., warts and all. Defying criticism of the deal, Tobin lays out how Boston Scientific management corrected Guidant's problems--and why the new company will thrive.